Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection

被引：23

作者：

Girard, PM ^{[1
]}

Schneider, V

Dehée, A

Mariot, P

Jacomet, C

Delphin, N

Damond, F

Carcelain, G

Autran, B

Saimot, AG

Nicolas, JC

Rozenbaum, W

机构：

[1] Hop Rothschild, Serv Malad Infect & Trop, F-75571 Paris, France

[2] Hop Rothschild, Virol Lab, F-75571 Paris, France

[3] Grp Hosp Bichat Claude Bernard, Virol Lab, Paris, France

[4] Grp Hosp Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France

[5] Hop La Pitie Salpetriere, URA CNRS 625, Lab Immunol Cellulaire, Paris, France

来源：

AIDS | 2001年 / 15卷 / 02期

关键词：

D O I：

10.1097/00002030-200101260-00020

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：275 / 277

页数：3

共 7 条

[1] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].

Carpenter, CCJ ;

Cooper, DA ;

Fischl, MA ;

Gatell, JM ;

Gazzard, BG ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schechter, M ;

Schooley, RT ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390

[2] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[3] Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy [J].

Harrigan, PR ;

Whaley, M ;

Montaner, JSG .

AIDS, 1999, 13 (08) :F59-F62

[4] Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection:: Results of the ANRS 053 trial [J].

Hoen, B ;

Dumon, B ;

Harzic, M ;

Venet, A ;

Dubeaux, B ;

Lascoux, C ;

Bourezane, Y ;

Ragnaud, JM ;

Bicart-See, A ;

Raffi, F ;

Beauvais, L ;

Fleury, H ;

Séréni, D .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :1342-1346

[5] The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses [J].

Markowitz, M ;

Vesanen, M ;

Tenner-Racz, K ;

Cao, YZ ;

Binley, JM ;

Talal, A ;

Hurley, A ;

Ji, X ;

Chaudhry, MR ;

Yaman, M ;

Frankel, S ;

Heath-Chiozzi, M ;

Leonard, JM ;

Moore, JP ;

Racz, P ;

Nixon, DF ;

Ho, DD .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03) :527-537

[6] HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment [J].

Neumann, AU ;

Tubiana, R ;

Calvez, V ;

Robert, C ;

Li, TS ;

Agut, H ;

Autran, B ;

Katlama, C .

AIDS, 1999, 13 (06) :677-683

[7] Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy [J].

Zhang, LQ ;

Ramratnam, B ;

Tenner-Racz, K ;

He, YX ;

Vesanen, M ;

Lewin, S ;

Talal, A ;

Racz, P ;

Perelson, AS ;

Korber, BT ;

Markowitz, M ;

Ho, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1605-1613

← 1 →